Clinical trials
Active, not recruiting Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 3 |
| AbbVie | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Children's Cancer Group, China | 1 |
| Dana-Farber Cancer Institute | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| National Cancer Institute (NCI) | 1 |
| Orca Biosystems, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia, Biphenotypic, Acute | 5 |
| Burkitt Lymphoma | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Myelodysplastic Syndromes | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myelomonocytic, Acute | 1 |
| Leukemia, Myelomonocytic, Juvenile | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.